Who are Can-Fite BioPharma Ltd.'s main suppliers?

Can-Fite BioPharma Ltd. (CANF) key suppliers include: OPHTHALIX, Novo Nordisk A/S, Novo Nordisk A/S, ORANY, ORANY. View the full supplier network at chainsifter.com/chain/CANF.

Who are Can-Fite BioPharma Ltd.'s major customers?

Can-Fite BioPharma Ltd. (CANF) key customers include: CHONG-KUN-DANG-PHARMACEUTICALS-CORP, EWOPHARMA-AG, GEBRO-HOLDING-GMBH, Novo Nordisk A/S, Novo Nordisk A/S and 2 more. View the full customer network at chainsifter.com/chain/CANF.

What sector is Can-Fite BioPharma Ltd. in?

Can-Fite BioPharma Ltd. (CANF) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

CANF Supply Chain: Can-Fite BioPharma Ltd. Supplier List & 14 Relationships

5Suppliers

7Customers

2Debt Items

20Related Chains

Can-Fite BioPharma Ltd. Suppliers

Ticker	Name	Confidence	Evidence
OPHTHALIX	OPHTHALIX	90%	In addition, immediately prior to the Merger, OphthaliX sold on an “as is” basis to us all the ordinary shares of Eye-Fite
NVO	Novo Nordisk A/S	72%	elopment of, facilities to manufacture a sufficient supply of our product candidates. We do not have the resources, facilities or experience to manufacture our product candidates for commercial purpo…
NVO	Novo Nordisk A/S	72%	Reciprocal relationship from NVO graph: Reciprocal relationship from CANF graph: elopment of, facilities to manufacture a sufficient supply of our product candidates. We do not have the resources, fa…
ORANY	ORANY	72%	e Public Health Service Act (IPHS) and the Federal Food, Drug, and Cosmetic Act (FDCA), as amended, and the regulations promulgated thereunder, and other federal and state statutes and regulations go…
ORANY	ORANY	72%	Reciprocal relationship from ORANY graph: Reciprocal relationship from CANF graph: e Public Health Service Act (IPHS) and the Federal Food, Drug, and Cosmetic Act (FDCA), as amended, and the regulati…

Can-Fite BioPharma Ltd. Customers

Ticker	Name	Confidence	Evidence
CHONG-KUN-DANG-PHARMACEUTICALS-CORP	CHONG-KUN-DANG-PHARMACEUTICALS-CORP	85%	obligation amounted to $ 1,581 and $ 1,986 , respectively and are presented under deferred revenues. During the year ended December 31, 2025, the Company recognized revenues in the amount of $ 405 wh…
EWOPHARMA-AG	EWOPHARMA-AG	85%	obligation amounted to $ 1,581 and $ 1,986 , respectively and are presented under deferred revenues. During the year ended December 31, 2025, the Company recognized revenues in the amount of $ 405 wh…
GEBRO-HOLDING-GMBH	GEBRO-HOLDING-GMBH	85%	obligation amounted to $ 1,581 and $ 1,986 , respectively and are presented under deferred revenues. During the year ended December 31, 2025, the Company recognized revenues in the amount of $ 405 wh…
NVO	Novo Nordisk A/S	72%	elopment of, facilities to manufacture a sufficient supply of our product candidates. We do not have the resources, facilities or experience to manufacture our product candidates for commercial purpo…
NVO	Novo Nordisk A/S	72%	Reciprocal relationship from NVO graph: Reciprocal relationship from CANF graph: elopment of, facilities to manufacture a sufficient supply of our product candidates. We do not have the resources, fa…
ORANY	ORANY	72%	Reciprocal relationship from ORANY graph: Reciprocal relationship from CANF graph: Reciprocal relationship from ORANY graph: Reciprocal relationship from CANF graph: e Public Health Service Act (IPHS…
ORANY	ORANY	72%	e Public Health Service Act (IPHS) and the Federal Food, Drug, and Cosmetic Act (FDCA), as amended, and the regulations promulgated thereunder, and other federal and state statutes and regulations go…

Can-Fite BioPharma Ltd. Debt Obligations

Instrument	Description	Confidence	Evidence
CANF-DEBT	Debt stack $71,000	90%	Market cache reports total debt of $71,000.
CANF-DEBT-8466	Warrants outstanding: 60000000	90%	xbrl warrant detail from xbrl 2024-08-08.

Can-Fite BioPharma Ltd. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Can-Fite BioPharma Ltd..

Can-Fite BioPharma Ltd. Ownership

Holder	Name	Confidence	Evidence
CANF-OWNER-MORGAN-STANLEY	MORGAN STANLEY	90%	13F overlay lists MORGAN STANLEY as top holder; 1 tracked holders.

Can-Fite BioPharma Ltd. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
EVAX	Evaxion A/S	100.00	2
CRBP	Corbus Pharmaceuticals Holdings, Inc.	100.00	2
IPHA	Innate Pharma S.A.	100.00	2
NONOF	Novo Nordisk A/S	100.00	2
ORANY	ORANGE	100.00	1	['customer', 'supplier']
SDGR	Schrödinger, Inc.	100.00	2
ALNY	Alnylam Pharmaceuticals, Inc.	100.00	2
HIMS	Hims & Hers Health, Inc.	100.00	2
ASND	Ascendis Pharma A/S	100.00	2
LLY	Eli Lilly and Company	100.00	2
D	Dominion Energy, Inc.	50.00	2
FENC	Fennec Pharmaceuticals Inc.	50.00	2
EQR	Equity Residential	50.00	2
CNOB	ConnectOne Bancorp, Inc.	50.00	2
CLNE	Clean Energy Fuels Corp.	50.00	2
AYTU	Aytu BioPharma, Inc.	50.00	2
AMZE	Amaze Holdings, Inc.	50.00	2
CHUC	Charlie's Holdings, Inc.	50.00	2
CORT	Corcept Therapeutics Incorporated	50.00	2
DFTX	Definium Therapeutics, Inc.	50.00	2

Can-Fite BioPharma Ltd. Supply Chain